3 months ago
BCRX
AnalystsStacy KuStacy Ku's Stock Forecasts
AnalystsStacy Ku
Sectors:
Analyst Ranking
Bottom 19%
#4235 out of 5184 analysts
Average Return
-8.43%
Win Rate
20%1 out of 5
Risk vs Reward
Poor
Good
Stacy Ku's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kalvista Pharmaceuticals IncKALV | +79.79% | $8.76 | $15.75 | 2025-01-07 - 2026-01-06 | Strong Buy |
Stacy Ku Analyst Color
Get additional color on Stacy Ku's coverage of popular stocks
Stacy Ku's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Supernus Pharmaceuticals IncSUPN | 1 | Strong Buy | $60.00 | +24.35% | Maintains | 3 months ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Strong Buy | $30.00 | +341.83% | Reinstates | 3 months ago |
Kalvista Pharmaceuticals IncKALV | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Verrica Pharmaceuticals IncVRCA | 1 | Strong Buy | $100.00 | N/A | Maintains | a year ago |
Astria Therapeutics IncATXS | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.